{"id":46742,"date":"2022-07-29T16:01:59","date_gmt":"2022-07-29T14:01:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-comprehensive-metabolic-panel-cmp-testing-markets-2021-2022-2029-researchandmarkets-com\/"},"modified":"2022-07-29T16:01:59","modified_gmt":"2022-07-29T14:01:59","slug":"global-comprehensive-metabolic-panel-cmp-testing-markets-2021-2022-2029-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-comprehensive-metabolic-panel-cmp-testing-markets-2021-2022-2029-researchandmarkets-com\/","title":{"rendered":"Global Comprehensive Metabolic Panel (CMP) Testing Markets 2021-2022 & 2029 – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Comprehensive Metabolic Panel (CMP) Testing Market Analysis by Disease Type (Diabetes, Kidney Disease, Liver Disease), by End User (Point Of Contact (PoC), Laboratories), and by Region – Forecast to 2029”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global comprehensive metabolic panel (CMP) testing market size is estimated to be USD 12.5 billion in 2021 and is expected to witness a CAGR of 8.42% to 2029\n<\/p>\n

\nGrowth in awareness concerning early diagnosis and treatment of diseases is a key driver for the growth of the global comprehensive metabolic panel (CMP) testing market.\n<\/p>\n

\nAdditionally, rise in geriatric population base globally and increase in global cases of chronic diseases in the comprehensive metabolic panel (CMP) testing market are some of the other drivers propelling the market growth. Nevertheless, absence of skilled professionals to operate the testing panels and strict regulatory guidelines are expected to restrain the global market growth.\n<\/p>\n

\nBy Disease Type<\/strong>\n<\/p>\n

\nIn 2021, the kidney disease segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.\n<\/p>\n

\nThis is attributed to the increase in prevalence of kidney disease and maximum application of analytes worldwide. Diabetes segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing cases of diabetes globally which is driving the comprehensive metabolic panel testing market.\n<\/p>\n

\nBy End User<\/strong>\n<\/p>\n

\nIn 2021, the laboratories segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.\n<\/p>\n

\nThis is attributed to the easy accessibility, increasing market penetration, better usage worldwide. Point of contact (PoC) segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing demand from consumers for improved and efficient diagnosis, laboratory testing of CMP is expected to maintain the leading position in the market.\n<\/p>\n

\nRegional Insights<\/strong>\n<\/p>\n

\nIn 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the high disease liability, presence of major players in the region, increase in the share of healthcare expenditure in the per capita income, growth in initiatives from government, accessibility of technological advanced products in the region.\n<\/p>\n

\nAsia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the economic development in the region, growing government and corporate investment in healthcare sector, increasing travel tourism in the developing economies, and availability of skilled labour forces at economic costs, are the major factors in this region.\n<\/p>\n

\nCompetitor Insights<\/strong>\n<\/p>\n

\nThe leading players operating in the comprehensive metabolic panel (CMP) testing industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.\n<\/p>\n

\nCompanies Mentioned<\/strong>\n<\/p>\n